We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
(+7.8%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$193M |
| 2 |
Gilead Sciences
GILD
|
+$115M |
| 3 |
Tencent Music
TME
|
+$83.5M |
| 4 |
Kanzhun
BZ
|
+$76.7M |
| 5 |
Wheaton Precious Metals
WPM
|
+$68.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$189M |
| 2 |
Williams Companies
WMB
|
+$155M |
| 3 |
AYX
Alteryx Inc
AYX
|
+$94.1M |
| 4 |
AbbVie
ABBV
|
+$87M |
| 5 |
Amgen
AMGN
|
+$78.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.44% |
| 2 | Healthcare | 17.1% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 10.38% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Cousins Properties
CUZ
$4.65B
| $554K | ﹤0.01% |
23,033
+4,049
| +21% | +$94.4K |
|
1302
MACOM Technology Solutions
MTSI
$19.2B
| $548K | ﹤0.01% |
5,729
-299
| -5% | -$26.4K |
|
|
LPRO
1303
DELISTED
Open Lending Corp
LPRO
| $547K | ﹤0.01% |
87,408
+8,613
| +11% | +$63.5K |
|
1304
Okta
OKTA
$32.9B
| $544K | ﹤0.01% |
5,201
-399,899
| -99% | -$36.9M |
|
1305
DXP Enterprises
DXPE
$2.85B
| $541K | ﹤0.01% |
10,074
+912
| +10% | +$34.3K |
|
|
SRCL
1306
DELISTED
Stericycle Inc
SRCL
| $534K | ﹤0.01% |
10,121
-1,316
| -12% | -$66.2K |
|
1307
Tango Therapeutics
TNGX
$3.94B
| $533K | ﹤0.01% |
67,115
+66,959
| +42,922% | +$718K |
|
1308
Ennis
EBF
$540M
| $527K | ﹤0.01% |
25,707
-940
| -4% | -$19.2K |
|
1309
Glacier Bancorp
GBCI
$5.85B
| $524K | ﹤0.01% |
13,014
+3,434
| +36% | +$133K |
|
1310
ResMed
RMD
$32.9B
| $519K | ﹤0.01% |
2,620
+2,458
| +1,517% | +$450K |
|
|
AMK
1311
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $517K | ﹤0.01% |
14,611
+636
| +5% | +$20.8K |
|
1312
Carter's
CRI
$1.07B
| $517K | ﹤0.01% |
6,102
-2,476
| -29% | -$197K |
|
1313
Perrigo
PRGO
$1.88B
| $512K | ﹤0.01% |
15,903
-976
| -6% | -$30.8K |
|
1314
Southwest Gas
SWX
$6.28B
| $506K | ﹤0.01% |
6,641
-814
| -11% | -$52.8K |
|
|
AZPN
1315
DELISTED
Aspen Technology Inc
AZPN
| $505K | ﹤0.01% |
2,370
-207
| -8% | -$40.8K |
|
1316
AutoNation
AN
$6.46B
| $505K | ﹤0.01% |
3,051
+206
| +7% | +$30.3K |
|
1317
Evertec
EVTC
$1.69B
| $505K | ﹤0.01% |
12,659
| – | – |
|
1318
Alcoa
AA
$12.2B
| $504K | ﹤0.01% |
14,908
-1,114
| -7% | -$32.6K |
|
1319
DT Midstream
DTM
$12.8B
| $503K | ﹤0.01% |
8,229
-441
| -5% | -$24.5K |
|
1320
Amylyx Pharmaceuticals
AMLX
$3.64B
| $500K | ﹤0.01% |
175,983
+73,483
| +72% | +$961K |
|
1321
SelectQuote
SLQT
$87.6M
| $499K | ﹤0.01% |
249,455
-1,047
| -0.4% | -$1.56K |
|
1322
Antero Midstream
AM
$10B
| $499K | ﹤0.01% |
35,468
-16,064
| -31% | -$205K |
|
1323
New Jersey Resources
NJR
$5.43B
| $496K | ﹤0.01% |
11,550
+764
| +7% | +$32.2K |
|
1324
Kulicke & Soffa
KLIC
$4.16B
| $495K | ﹤0.01% |
+9,840
| New | +$492K |
|
1325
OneMain Financial
OMF
$6.97B
| $494K | ﹤0.01% |
9,669
-807
| -8% | -$38.5K |
|
Similar funds
Federated Hermes's Q1 2024 Portfolio in Review
As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
- Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
- Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
- Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
- Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
- Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
- Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.
Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.